Table 3.
Total, Fatal, and Nonfatal Acute Coronary Heart Disease (CHD) Events.
| Black vs White, Hazard Ratio (95% CI) | ||
|---|---|---|
| Men | Women | |
| Total CHD | ||
| Model 1a | 1.15 (0.94–1.41) | 1.48 (1.15–1.90) |
| Model 2b | 1.04 (0.84-–1.29) | 1.25 (0.96–1.62) |
| Model 3c | 0.93 (0.74–1.16) | 0.95 (0.72–1.25) |
| Model 4d | 0.87 (0.69–1.08) | 0.90 (0.68–1.20) |
| Fatal CHD | ||
| Model 1a | 2.18 (1.55–3.06) | 1.93 (1.23–3.03) |
| Model 2b | 1.78 (1.24–2.56) | 1.63 (1.02–2.62) |
| Model 3c | 1.50 (1.02–2.19) | 1.20 (0.73–1.97) |
| Model 4d | 1.34 (0.91–1.96) | 1.14 (0.69–1.99) |
| Non-fatal CHD | ||
| Model 1a | 0.81 (0.63–1.06) | 1.31 (0.97–1.77) |
| Model 2b | 0.78 (0.60–1.03) | 1.10 (0.80–1.52) |
| Model 3c | 0.72 (0.54–0.95) | 0.85 (0.61–1.19) |
| Model 4d | 0.68 (0.51–0.91) | 0.81 (0.58–1.15) |
a
Adjusted for age and region of residence.
b
Adjusted for model 1 covariates plus education level and income.
c
Adjusted for model 2 covariates plus total cholesterol, high-density lipoprotein cholesterol, smoking status, systolic blood pressure, diabetes, and use of antihypertensive and statin medications.
d
Adjusted for model 3 covariates plus body mass index, estimated glomerular filtration rate of less than 60 mL/min, log-transformed high-sensitivity C-reactive protein, and log-transformed albumin-to-creatinine ratio.